Investor
The company's former CEO, president and CFO are each facing multiple counts of wire fraud, bank fraud and mail fraud, among other charges.
Accel and 8VC headlined the Mount Sinai-affiliated startup's Series A.
The announcement comes not long after competitor One Drop began rolling out its similar offering in Apple Stores and Walmarts.
The new funding news comes less than a year after the company closed an $8 million Series A round.
The online tool helps users raise funds and coordinate care from peers.
The startup develops non-invasive blood tests that achieve early cancer detection and improve treatment selection.
BlueCross BlueShield Venture Partners led the round with participation from Threshold Ventures, F-Prime Capital and Wellframe's existing clients.
CEO Adrian Gilmore said the company is looking at strategic partnerships, M&A and other general scaling of the business in the year to come.